BP
KRTX

Ballentine Partners’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Ballentine Partners’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,403
Closed -$304K – 655
2023
Q2 		$304K Sell
1,403
-768
-35% -$167K 0.01% 445
2023
Q1 		$394K Buy
2,171
+528
+32% +$95.9K 0.01% 352
2022
Q4 		$323K Buy
1,643
+483
+42% +$94.9K 0.01% 362
2022
Q3 		$261K Buy
+1,160
New +$261K 0.01% 375